Old Web
English
Sign In
Acemap
>
Paper
>
Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor
Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor
2020
S. H. Kizilbash
Anthony B. El-Khoueiry
R E Lerner
P. C. Ma
M. Almubarak
K. Mody
M.E. Burkard
M. Guarino
J. Jenab-Wolcott
N Sankar
G. Choy
L Espiritu
X Zhang
A. Luria
Fabio Benedetti
E. C. Dees
Keywords:
c-Met inhibitor
Pharmacology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]